MARCHINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 11.726
EU - Europa 6.887
AS - Asia 4.382
SA - Sud America 478
AF - Africa 172
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 13
AN - Antartide 1
Totale 23.687
Nazione #
US - Stati Uniti d'America 11.305
CN - Cina 1.748
IT - Italia 1.417
RU - Federazione Russa 1.353
PL - Polonia 1.307
SG - Singapore 1.285
DE - Germania 788
GB - Regno Unito 426
BR - Brasile 391
FR - Francia 371
VN - Vietnam 356
CA - Canada 351
HK - Hong Kong 343
UA - Ucraina 339
SE - Svezia 310
FI - Finlandia 239
TR - Turchia 143
KR - Corea 133
ZA - Sudafrica 123
IN - India 101
IE - Irlanda 79
MX - Messico 48
NL - Olanda 44
JP - Giappone 38
AR - Argentina 37
BD - Bangladesh 37
BE - Belgio 36
AT - Austria 35
ES - Italia 33
CZ - Repubblica Ceca 27
EU - Europa 26
PK - Pakistan 26
IR - Iran 22
EG - Egitto 16
RO - Romania 16
BH - Bahrain 15
IQ - Iraq 15
LT - Lituania 14
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
UZ - Uzbekistan 12
VE - Venezuela 11
ID - Indonesia 10
TW - Taiwan 10
AU - Australia 9
KE - Kenya 9
CL - Cile 7
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
PT - Portogallo 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
CO - Colombia 6
MA - Marocco 6
MY - Malesia 6
PH - Filippine 6
RS - Serbia 6
HN - Honduras 5
KG - Kirghizistan 5
PY - Paraguay 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
LV - Lettonia 4
PE - Perù 4
SI - Slovenia 4
CH - Svizzera 3
DK - Danimarca 3
DZ - Algeria 3
EE - Estonia 3
HU - Ungheria 3
JM - Giamaica 3
MD - Moldavia 3
ML - Mali 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
SY - Repubblica araba siriana 3
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
NP - Nepal 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 23.668
Città #
Warsaw 1.152
Ashburn 998
Fairfield 992
Woodbridge 961
Jacksonville 812
Singapore 674
Houston 662
Chandler 601
San Jose 583
Ann Arbor 508
Wilmington 473
Seattle 464
Cambridge 356
Hong Kong 334
Boardman 332
Camerino 298
Nanjing 278
Beijing 252
Toronto 204
The Dalles 194
Los Angeles 179
New York 163
Dallas 153
Kraków 146
Dearborn 130
Seoul 128
San Mateo 126
Tongling 122
Helsinki 117
Johannesburg 113
Lauterbourg 112
Princeton 107
Lawrence 106
Columbus 100
Istanbul 100
Nanchang 98
Ho Chi Minh City 96
London 95
Ogden 92
Düsseldorf 83
Dublin 79
Moscow 77
Hanoi 74
Lachine 72
Buffalo 70
Milan 66
Kunming 62
Council Bluffs 60
Shanghai 57
Shenyang 57
São Paulo 51
Dong Ket 50
San Diego 48
Centro 47
Chicago 45
Guangzhou 45
Hebei 45
Munich 44
Tianjin 44
Jinan 42
Orem 42
Jiaxing 41
Santa Clara 41
Rome 40
Montreal 38
Brussels 34
Hefei 34
Tokyo 34
Verona 32
Denver 31
Falls Church 31
Changsha 30
Brooklyn 29
Zhengzhou 29
Venezia 28
Vienna 27
Hangzhou 26
Redwood City 26
Trieste 25
Valle 25
Chennai 24
Phoenix 24
Ningbo 23
Atlanta 22
Bologna 22
Da Nang 21
Athens 19
Brno 19
Philadelphia 19
Wuhan 19
Mumbai 18
Redondo Beach 18
Amsterdam 17
Napoli 17
San Francisco 17
Jinhua 16
Manchester 16
Nürnberg 16
Rio de Janeiro 16
Stockholm 16
Totale 15.651
Nome #
Antioxidant and antiproliferative activities of different varieties of cauliflower (Brassica oleracea var. botrytis) after cooking processes. 480
Complessi di rutenio con attività chemioterapica antitumorale 423
In vivo protein corona patterns of lipid nanoparticles 389
Personalized liposome–protein corona in the blood of breast, gastric and pancreatic cancer patients 388
The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery 364
VirF Relieves the Transcriptional Attenuation of the Virulence Gene icsA of Shigella flexneri Affecting the icsA mRNA-RnaG Complex Formation 336
The water soluble ruthenium(II) organometallic compound[Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Clsuppresses triple negative breast cancer growth by inhibiting tumorinfiltration of regulatory T cells 326
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition 325
Resveratrol fuels HER2 and ERα‐positive breast cancer behaving as proteasome inhibitor 324
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 320
Aspirin modulates LPS-induced nitric oxide release in rat glial cells 317
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 283
Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells 277
Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer 274
A novel 39-tRNAGlu-derived fragment acts as a tumor-suppressor in breast cancer by targeting nucleolin 272
Tailoring DNA vaccines: designing strategies against HER2-positive cancers 267
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 265
Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD) 261
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. 258
Cholesterol dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO Living Cells 256
HER2-Driven carcinogenesis: new mouse models for novel immunotherapies 255
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 254
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling 252
Tumor vessel compression hinders perfusion of ultrasonographic contrast agents 250
Azolate/phosphane Gold(I) compounds in antiproliferative therapy: a new frontier for the azolate gold(I) chemistry 250
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer 248
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2- positive breast carcinomas resistant to Lapatinib 246
Combination of Coenzyme Q10 intake and moderate physical activity counteracts mitochondrial dysfunctions in a SAMP8 mouse model Oxidative Medicine and Cellular Longevity. 245
NANOPARTICELLE LIPIDICHE MULTICOMPONENTI E PROCEDIMENTI PER LA LORO PREPARAZIONE 241
Azolate gold(I) phosphane complexes as innovative therapies for the treatment of HER2-driven breast cancer 239
Factors Determining the Superior Performance of Lipid/DNA/Protammine Nanoparticles over Lipoplexes. 237
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells 234
Getting the most from gene delivery by repeated DNA transfections 231
Cyclooxygenase-2 (COX2) gene silencing with siRNA could enhance DNA vaccination to inhibit established ErbB-2 carcinomas 229
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 229
IN VITRO AND IN VIVO STUDIES FOR THE TREATMENT OF BASAL LIKE BREAST CANCER (BLBC) WITH AZOLATE/PHOSPHANE GOLD(I) COMPOUNDS 229
Structure-function relationships in bovine thymus 20S proteasome: a fluorimetric study 229
Role of temperature-independent lipoplex-cell membrane interactions in the efficiency boost of multicomponent lipoplexes. 226
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 223
Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition 218
Tailoring lipoplex composition to the lipid composition of plasma membrane: a Trojan horse for cell entry? 217
Characterization of an inwardly rectifying chloride conductance expressed by cultured rat cortical astrocytes. 216
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients 216
Toward the Rational Design of Lipid Gene Vectors: Shape Coupling between Lipoplex and Anionic Cellular Lipids Controls the Phase Evolution of Lipoplexes and the Efficiency of DNA Release 214
Vaccination trials against bovine herpesvirus-1 212
Ruthenium Complexes with Antitumoral Chemiotherapy Activites 211
Antiproliferative Activity of a New (Arene)Ruthenium(II) Complex on a Model of Breast Cancer 207
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 206
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 202
Transfection efficiency boost by designer multicomponent lipoplexes 201
Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells 198
Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density 195
Transfection efficiency boost of cholesterol-containing lipoplexes 195
Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity 195
Novel Mechanisms of Cell Uptake in Lipid-Mediated Gene Delivery 192
Costrutto di acido nucleico, vettore e vaccino a DNA includenti detto costrutto 192
On the correlation between phase evolution of lipoplexes/anionic lipid mixtures and DNA release 189
p185neu encoding DNA and therapeuticaluses thereof 189
DNA release from cationic liposome/DNA complexes by anionic lipids 189
Homeostatic effects of adenosine on potentially neurotoxic glial cell activation. 188
Protective mechanisms of adenosine in neurons and glial cells. 187
LIBRERIA FAGICA DI FRAMMENTI DELLA PROTEINA HER2 186
Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules 186
Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes 185
P185neu-encoding DNA and therapeutical uses thereof 184
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 183
Surface adsorption of protein corona controls the cell uptake mechanism in efficient cationic liposome/DNA complexes in serum. 182
Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination 182
Two distinct inwardly rectifying conductances are expressed in long term dibutyryl-cyclic-AMP treated rat cultured cortical astrocytes. 180
Characterization of two voltage-dependent, inwardly rectifying currents in dibutyryl-cyclic AMP treated cortical astrocytes 178
Cationic lipid/DNA complexes manufactured by microfluidics and bulk self-assembly exhibit different transfection behavior 176
Surface area of lipid membranes regulates the DNA-binding capacity of cationic liposomes. 175
Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A 175
The Second Ascoli Piceno Conference on Gene Vacciantion in Cancer, October 9-11 2013 175
Mechanistic Understanding of Gene Delivery Mediated by Highly Efficient Multicomponent Envelope-Type Nanoparticle Systems 170
Cascading glial reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. 170
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 169
Glia-related pathomechanisms in Alzheimer' s disease: a therapeutic target? 166
Effect of pH on the structure of lipoplexes 164
Programmed packaging of multicomponent envelope-type nanoparticle system for gene delivery. 164
Effects of a supplementation with tart cherry (Prunus cerasus L.) juice and its kernel extract on antioxidant status and muscle health 163
Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. 163
p185neu-Encoding DNA and therapeutical uses thereof 160
Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes 160
Self-assembled ternary complexes of neutral liposomes, DNA and bivalent metal cations. Promising vectors for gene transfer? 158
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 156
Programmed packaging of multicomponent envelope-type nanoparticle system (MENS). 156
DNA codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici 155
DNA codificante p185neu e suoi usi terapeutici 155
Stathmin is required for normal mouse mammary gland development and Δ16HER2-driven tumorigenesis 151
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favors early tumor growth in syngeneic mice. 148
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 148
Mesenchymal/stromal gene expression signature relates to Basal-like breast cancers, identify bone metastasis and predicts resistance to therapies. 146
Efficient Delivery of DNA Using Lipid Nanoparticles 145
Structural stability against disintegration by anionic lipids rationalizes the efficency of cationic liposom/DNA complexes 145
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 141
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 137
Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth 134
Different expression of membrane conductances in cultured rat cortical astrocytes induced by intracellular cyclic-AMP elevation 129
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 127
Totale 21.708
Categoria #
all - tutte 88.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021799 0 0 0 0 0 0 0 0 0 116 424 259
2021/20221.362 90 314 37 60 95 84 52 96 128 117 154 135
2022/20231.653 172 43 88 214 171 239 10 140 300 103 124 49
2023/20241.224 158 75 82 42 55 138 46 40 139 41 26 382
2024/20253.941 145 69 292 153 133 184 520 1.019 318 300 225 583
2025/20264.999 407 339 432 810 616 441 968 442 240 304 0 0
Totale 24.016